AssetID: 55931515
Headline: UNCAPTIONED: Moderna And Merck Cancer Vaccine Breakthrough Raises Hopes For Wider Treatments
Caption: Moderna And Merck Cancer Vaccine Breakthrough Raises Hopes For Wider Treatments. Moderna and Merck have reported promising results for a personalised cancer vaccine designed to prevent melanoma from returning or spreading. The vaccine trains the immune system to specifically target mutations found in an individual patient's tumour, unlike treatments that can also affect healthy cells. A trial involving more than 1,000 melanoma patients found the vaccine combined with Keytruda helped prevent the disease from returning or spreading. Experts described the results as a major advance, with hopes that personalised mRNA vaccines could eventually transform treatment for multiple types of cancer. Merck and Moderna are also testing the approach in lung, bladder, kidney, pancreatic and stomach cancers, with further trial results expected over the next two years. Their treatment, intismeran autogene, combines a customised mRNA vaccine with Merck's immunotherapy drug Keytruda to help the immune system attack specific cancer cells. Earlier trial data showed the combination cut the risk of recurrence or death by 49% and distant spread or death by 59%. The latest trial remains ongoing, with researchers continuing to monitor patients to determine whether the treatment also extends overall survival. Instructions: THIS VIDEO MUST NOT BE EDITED FOR LENGTH TO COMBINE WITH OTHER CONTENT
Keywords: Health & Wellbeing,Moderna,Merck,cancer vaccine,melanoma,mRNA,intismeran autogene,Keytruda,cancer treatment,immunotherapy,personalised medicine
PersonInImage: